Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the efficacy and safety of PAC-14028 1% cream of
Amorepacific Corporation in patients with erythema-telangiectatic or papulopustular rosacea